Introduction: Atherosclerosis is partly a heritable disorder. Various genetic polymorphisms have been linked to the atherosclerotic process and its complications. Glu298Asp polymorphism of endothelial nitric oxide synthase gene is one such genetic marker for atherosclerosis. Aim of the work: To study the relationship between endothelial nitric oxide synthase gene polymorphism and atherosclerotic coronary and carotid arterial disease in Egyptian population. Patients and methods: Our study included 95 Egyptian patients with Egyptian father and mother, classified into two groups: Group 1; 63 patients with ischemic heart disease and Group 2; 32 control subjects and subjected to careful history taking, thorough clinical examination, standard twelvelead surface electrocardiogram, routine laboratory investigations, echo Doppler study, carotid arterial duplex, invasive coronary angiography and analysis of the endothelial NOS3 gene polymorphism using PCR-RFLP for detection of different genotype variants (Glu/Glu (GG), Glu/Asp (GT) and Asp/Asp (TT) genotype). Conclusion: Glu298Asp polymorphism in the endothelial nitric oxide synthase gene did not increase the susceptibility to coronary and carotid arteries disease in the studied patients.
Introduction
Atherosclerosis, a chronic inflammatory disease, underlies the pathogenesis of coronary artery disease (CAD). The molecular etiology of coronary atherosclerosis involves interaction of many genes and environmental factors. 22 Nitric oxide (NO) produced by the enzyme endothelial nitric oxide synthase (eNOS), has critical roles in the regulation of vascular homeostasis and prevention of atherogenesis by inhibiting leukocyte, platelet activation and smooth muscle cell proliferation. 17 Polymorphisms of eNOS gene were shown to be associated with CAD in some populations. 8 The guanine to thymine (Glu298Asp) polymorphism at position 894 of the eNOS gene (replacement of glutamate (G) by aspartate (T)) is under extensive study and T allele had been described as susceptibility allele for CAD in some studies. 28 There have been conflicting reports on the relationship between this polymorphism and CAD from studies done in various ethnic groups across the world. 11, 8 Therefore, we undertook the current study to investigate whether the eNOS Glu298Asp polymorphism is related to coronary and carotid arterial disease.
Aim of the work
To study the relationship between endothelial nitric oxide synthase gene polymorphism and atherosclerotic coronary and carotid arterial disease in Egyptian population.
Patients and methods
Our study included 63 patients consecutively admitted to our Institute (Fayoum University Hospital) and had angiographically defined CAD (>50% stenosis affecting at least one coronary vessel) and 32 individuals with normal coronary angiography. Inclusion criteria: All patients and controls were from the Egyptian population with Egyptian father and mother. Exclusion criteria: Acute renal failure, history of severe contrast reaction, uncontrolled infection, active bleeding, severe hypertension, coagulopathy (INR > 1.8) and patients of non Egyptian population or with non Egyptian father or mother.
3.1. Each patient included in the study was subjected to 1. Careful history taking and thorough physical examination.
Standard twelve-lead electrocardiogram (12-lead ECG):
For the assessment of cardiac rhythm, features suggesting myocardial ischemia (ST segment and T wave abnormalities and pathological Q waves), and voltage criteria of left ventricular hypertrophy. 3. Routine laboratory testing: Complete blood picture, fasting plasma glucose, blood urea, serum creatinine, SGOT, SGPT, PT, INR and complete lipid profile. 4. Echocardiography study: Both patients and control subject were studied by trans-thoracic echocardiography using a commercially available echocardiographic machines (Siemens), equipped with 3.5 MHz phased array transducer. M-mode echocardiography was used to assess chamber dimensions and calculation of the ejection fraction. Two dimensional echocardiography for the assessment of the overall ventricular systolic function by eyeballing and biplane Simpson's rule, assessment of the LV end-diastolic and systolic dimensions of regional wall motion abnormalities, valvular thickening, calcification, pericardial effusion or thickening and to rule out intra-cardiac masses or thrombi. Trans-mitral pulsed wave Doppler to measure peak E velocity, peak A velocity and the E/A ratio.
Carotid arterial duplex: High resolution B mode, color
Doppler and pulse Doppler ultrasonography of both carotid arteries were performed with an ultrasound machine: General Electric (GE) (Logic 7) equipped with 4-11 MHz linear array transducer and centralized reading was performed by one trained reader blinded to subject's characteristics and according to a standardized protocol. Patients were examined in the supine position with the head tilted backwards. After the carotid arteries were located by transverse scans the probe was rotated 90°to obtain and record a longitudinal image of the anterior and posterior walls. The maximum cIMT measured at the near and far walls of the right and left CCAs was scanned at least 1.5 cm proximal to the origin of the bulb (defined as the point of divergence of the walls of the CCAs). For each side, at least one optimal longitudinal image was frozen in end-diastole by electrocardiogram R-triggering. The IMT was measured only at a plaque-free site, along a 10 mm segment of the far wall of the CCA and measured as the distance between the lumen-intimal interface and the media-adventitia interface using an automated edge detection algorithm. The mean cutoff cIMT value was 0.89 mm. Image showing the maximum intimal-media thickness was stored and the average values were considered. For visualized plaques, the maximum diameter was determined and included in further analysis. The presence of plaques was defined as localized echo structures encroaching into the vessel lumen for which the wall thickening was at least 50% greater than that of the surrounding vessel wall. Furthermore, the grade of stenosis in the carotid and vertebral arteries was assessed through the increase in the peak systolic and end-diastolic velocities. 24 6. Coronary Angiography was done to all patients via a retrograde transfemoral approach, using Seldinger's technique. The angiograms were done in all standard views using right and left coronary catheters with the assessment of the number of diseased vessels, sites of lesions and estimation of the severity of stenosis. 7. Analysis of the endothelial NOS3 gene polymorphism: Three milliliters (3 ml) venous blood samples were withdrawn from subjects under aseptic conditions into sterile EDTA vacutainer tubes for DNA extraction. The samples were stored at À200°C. The test was done in five main steps: Extraction of genomic DNA from peripheral blood leucocytes of EDTA anti-coagulated blood. Amplification of the extracted DNA. Detection of PCR amplification products using agarose gel electrophoresis. The amplified products were digested with (MboI) restriction enzyme. The digested products were then analyzed by electrophoresis on agarose gel containing ethidium bromide and visualized by ultraviolet light transillumination for determination of Glu298 fi Asp endothelial nitric oxide synthase genotypes.
Statistical analysis
Collected data were computerized and analyzed using the Statistical Package for Social Science (SPSS) version 16.
Descriptive statistics were used to describe variables; percent, proportion for qualitative variables, mean SD and range for Quantitative variables. Comparison between groups was done using the Chi-Square test for qualitative variables, independent t-test and ANOVA test for quantitative variables. Pearson correlation was done between two quantitative variables to test association between variables. P values with significance of less than 5% were considered statistically significant.
Results

Baseline characteristics
Our study included 63 patients with coronary artery disease (group 1) and 32 age-and sex-matched subjects with normal coronary angiography (group 2). In group 1: 16 patients were females (25.4%) and 47 were males (74.6%), their age ranged between 30 and 67 years with mean age and standard deviation (SD) 51.71 ± 8.97 years. In group 2: 17 patients were females (53.1%) and 15 were males (46.9%), their age ranged between 20 and 70 years with mean age and SD 46.97 ± 11.11 years.
There was a significant differences in the prevalence of male gender (P value = 0.027), smoking (P = 0.049), DM (P value = 0.008), and hypertension (P value = 0.044). There was no significant difference in the prevalence of family history for CAD (P value = 0.293), obesity (P value = 0.17) between the patients and controls. There was a highly significant level of total cholesterol, LDL, triglyceride (P value = <0.0001) and FBS levels (P value = 0.003) in patients of group 1 when compared to the control group as shown in Tables 1-3 .
Genotype distribution in the studied population
In group 1: 63.5% of the patients (n = 40) were GG genotype, 33.3% of the patients (n = 21) were GT genotype and 3.2% of the patients (n = 2) were TT genotype. In group 2: 53.1% of the control group (n = 17) were GG genotype, 43.8% (n = 14) were GT genotype and 3.1% (n = 1) were TT genotype. There was no significant statistical difference in the genotype distribution of GG genotype, GT genotype and TT genotype between group 1 and 2 (P value = 0.605). There was no significant statistical difference in the G and T allele frequency between group 1 and 2 (P value = 0.531) as shown in Table 4 . In Group 1: 59.6% (n = 28) of males were GG genotype and 38.3% (n = 18) were GT genotype and 2.1% (n = 1) were TT genotype. On the other hand 75% (n = 12) of females were GG genotype and 18.8% (n = 3) were GT genotype and 6.2% (n = 1) were TT genotype. There was no significant statistical difference the genotype frequency in males and females (P value = 0.29). There was no significant statistical difference in the genotype distribution between smokers and non smokers (P value = 0.35), diabetic and non diabetic (P value = 0.16), hypertensive and normotensive (P value = 0.45), patients with and without family history of CAD (P value = 0.68). There was significantly higher GT and TT genotype in obese patients when compared to non obese (P value = 0.015). There was no significant statistical difference in the genotype distribution between patients presented with and without acute STEMI (P value = 0.35). There was no significant statistical difference in the genotype distribution between patients with impaired LV systolic function when compared to patients with normal LV systolic function (P value = 0.08).There was no significant statistical difference in the genotype distribution of patients with single vessel disease when compared to patients with two vessel and multi vessel coronary artery disease (P value = 0.38) as shown in Tables 4-9.
Carotid intima media thickness
Our study included 96 patients examined by carotid Doppler and cIMT was measured bilaterally. There was highly significant cIMT in male patients (P value = 0.008), diabetic (P value = 0.006), hypertensive (P value = 0.006), patients with hypercholesterolemia (P value = 0.003) and patients with CAD compared to those with normal coronaries (1.060 ± 0.1386 vs. 0.809 ± 0.1634, P value = <0.0001). The cIMT was not significantly increased in patients with endothelial nitric oxide synthase enzyme gene polymorphism(GG,0.981 ± 0.1807;GT,0.977 ± 0.2001;TT,0.867 ± 0.2517; P value = 0.599) and there was no significant difference in the G and T allele frequency in patients with higher cIMT when compared to patients with normal cIMT (P value = 0.8) as shown in Tables 10 and 11.
Discussion
In addition to established risk factors, genetic factors may have important role in the pathogenesis of coronary atherosclerosis. Using the approach of epidemiological studies; it is possible to identify weak susceptible genes in polygenic diseases like coronary heart disease. 33 Due to the protective roles of NO against important events during atherogenesis, the NOS3 gene has been identified as having roles in deciding susceptibility to coronary heart disease. 20, 35 Glu298Asp polymorphism of endothelial nitric oxide synthase gene is one such genetic marker for atherosclerosis that has been extensively studied across the world. The Glu298 fi Asp Endothelial Nitric Oxide Synthase gene polymorphism, with the substitution of G by T (replacement of glutamate by aspartate) at nucleotide position 894 in exon 7 reduces the activity of the enzyme, thereby resulting in a decrease in the production of nitric oxide. 19, 26 Therefore, the Glu298Asp polymorphism may predispose the individual to an increased risk for atherosclerosis and its complications. There have been conflicting reports on the relationship between this polymorphism and coronary artery disease, functional changes in the endothelium and carotid intima-media thickness (cIMT) from studies done in various ethnic groups across the world. 18, 32 Our study included 63 patients who had angiographically defined coronary artery disease (>50% stenosis affecting at least one coronary vessel) and 32 individuals with normal coronary angiograms as the control group. All patients and controls were from the Egyptian population with Egyptian father and mother. Our study showed that the heterozygous and homozygous Asp mutants were not significantly associated with the occurrence of coronary artery disease. 63.5% of CAD patients were Glu/Glu (GG) genotype, 33.3% were Glu/Asp (GT) genotype and 3.2% were Asp/Asp (TT) genotype while in the control group, 53.1% of were Glu/Glu genotype, 43.8% were Glu/Asp genotype and 3.1% of the control group were Asp/Asp genotype (P value = 0.605).
Our results came in agreement with case control studies done in Taiwan and Korea and found no evidence of association between the Asp variant of the endothelial nitric oxide synthase enzyme gene and coronary artery disease. 35, 16 On the other hand 12 in UK population showed that Asp298 homozygosity was significantly associated with angiographic CAD, the frequency of the Asp homozygous and the T allele, in the case and control groups were (35.9% and 47.8%, vs. 10.2% and 31.2%, respectively, P < 0.0001). 2 Found significantly higher Asp/Asp carriers (Asp homozygotes) in coronary artery disease patients when compared to the normal control (15.9% vs. 6.1%, P value = 0.01) 36, 5 reported positive association between endothelial nitric oxide synthase enzyme gene polymorphism and the occurrence of coronary artery disease.
Our study revealed no significant difference in the distribution of the T allele and G allele in patients with CAD compared to the control group (27.4 vs. 32.6 and 72.6% vs. 67.4%, P value = 0.531). Our results came in agreement with 6, 9 in the Australian Caucasian population who found no association between endothelial nitric oxide synthase enzyme gene polymorphism and the occurrence of coronary artery disease. Also 34, 16 found no association between the frequency of T allele and coronary artery disease in Taiwan and Korean population. On the other hand 12 showed that T allele was significantly associated with angiographic coronary artery disease (P value < 0.0001).
In our study, the severity of coronary artery disease was not significantly associated with the heterozygous and homozygous Asp mutants (P value = 0.38). Our results came in agreement with 6, 9 in the Australian Caucasian population who found no association between the frequency of the T allele and the severity of coronary artery disease. 9 On the other hand 2 observed an association between the T7863C polymorphism and the Duke scoring system, a prognostic index that considers not only the number of stenosed vessels but also the percentage of narrowing of the major vessels and the anatomical localization of the stenosis.
Subgroup analysis of our study revealed that the Asp variant was not significantly associated with male sex (P value = 0.4), hypertension (P value = 0.45), diabetes mellitus (P value = 0.16), smoking (P value = 0.35) and positive family history for CAD 15 showed that the association between CAD and the Asp variant was not significant in any of the subgroups of CAD patients based on age, sex, status of hypertension, diabetes and smoking positive family history for CAD. On the other hand 13 showed that Asp allele occurred more frequently in the subgroups of CAD patients: diabetes mellitus (P < 0.001), smoking (P < 0.001), hypertension (P = 0.03), family history of coronary artery disease (P = 0.02) and dyslipidemia (P = 0.02).
Our results suggested that the heterozygous and homozygous Asp mutants were significantly associated with increased body mass index (P value = 0.015). Our results came in agreement with. 12 On the other hand in the Australian Caucasian population, the T allele frequency was not associated with increased body mass index. 6, 9 Our study results showed that the heterozygous and homozygous Asp mutants were not significantly associated with the occurrence of acute STEMI (P value = 0.35). Our results came in agreement with 13 who concluded that the Glu298ASP polymorphism of the endothelial nitric oxide synthase gene is associated with STEMI in Mexican population. Similarly 11, 12, 15 demonstrated possible correlations between the endothelial nitric oxide synthase enzyme gene polymorphism Glu298Asp and acute ST elevation myocardial infarction.
Our study results showed that the heterozygous and homozygous Asp mutants were not significantly associated with the occurrence of left ventricular systolic dysfunction (P value = 0.085). Our results came in agreement with 15 who showed significant association between Asp mutant and acute STEMI and development of left ventricular systolic dysfunction. Similarly 32 demonstrated possible correlations between the endothelial nitric oxide synthase enzyme gene polymorphism Glu298Asp and left ventricular dysfunction. Carotid intima-media thickness (cIMT) has been widely used as a surrogate marker of atherosclerotic disease 31 , may predict the risk of cardiac events as myocardial infarction, angina pectoris and repeated coronary intervention 5 and the involvement of other arterial beds with atherosclerosis. 23 Several genetic variants have been examined in relation to carotid atherosclerosis, more often by association than by linkage analysis. 10,21,3 27 observed paradoxical increase in the carotid arterial wall thickness and hyperplasic response of the arterial wall in response to carotid artery ligation in eNOS-mutant mice, indicating that a primary defect in the NOS/NO pathway may promote abnormal remodeling and pathologic changes in vessel wall morphology associated with atherosclerosis.
Our study revealed significantly higher cIMT in males, diabetic, hypertensive and patients with high total cholesterol and LDL levels. Our results came in agreement with 1 who showed that male gender (P = 0.006), older age (P < 0.001), smoking habit (0.002), hypertension (P = 0.002), diabetes mellitus (P = 0.062), high triglycerides level (P = 0.019) and impaired fasting blood glucose level (P = 0.036) are related to greater cIMT values. Similarly 4 showed that cIMT is associated with increasing age, male gender, high SBP, high LDL-C, current smoking, impaired fasting glucose and diabetes mellitus.
Our study showed that cIMT significantly increased in patients with coronary artery disease compared to those with normal coronaries (cIMT 1.060 ± 0.1386 vs. 0.809 ± 0.1634 mm, P value = <0.0001).Our results came in agreement with 29 who reported good sensitivity of increased cIMT in predicting the risk of coronary artery disease and cardiac events. On the other hand, 7, 14 reported no sensitivity of increased cIMT in predicting the presence of coronary artery disease.
Our study suggested that endothelial nitric oxide synthase enzyme gene polymorphism is not associated with increased cIMT (Glu/Glu: 0.981 ± 0.1807 mm, Glu/Asp: 0.977 ± 0.2001 mm, Asp/Asp: 0.867 ± 0.2517 mm; P value = 0.599) and Asp variant was not significantly associated with increased cIMT (P value = 0.8). Our results came in agreement with 30 who found no association between increased cIMT and endothelial nitric oxide synthase enzyme gene polymorphism (average cIMT: Asp/Asp: 0.77 ± 0.11 mm; Glu/Glu and Glu/Asp: 0.80 ± 0.12 mm, P = NS) .On the other hand 25 found significantly greater cIMT in patients with Asp/Asp genotype displayed a (Asp/Asp: 0.45 ± 0.03 mm, Glu/Glu: 0.37 ± 0.1 mm, Glu/Asp: 0.35 ± 0.1 mm, P = 0.0002).
Several issues could account for discrepancy in the results of endothelial nitric oxide synthase gene polymorphism in our study compared to other clinical studies especially random type I errors in positive studies; lack of power in negative studies; population stratification; genetic heterogeneity; gene-environment interactions modulating gene regulation and expression.
Study limitations and recommendations
In our study, ethnic admixture was minimized to the maximum possible extent by including only individuals of Egyptian origin. We performed our study on a small sample of coronary artery disease patients from Fayoum City and our results suggest that polymorphism of Glu2983Asp and T7863C of the eNOS gene does not increase the susceptibility to coronary and carotid arteries disease in the studied patients. Further studies are warranted with larger sample size to investigate whether polymorphisms of the eNOS gene, both alone and in combination with the endothelial NO function, could represent a useful genetic markers for identifying Egyptian individuals at risk for the development of coronary and carotid arteries disease.
